Amarin News
Most Popular Amarin Story
AMR101 - 15 top blockbuster contenders
The drug: AMR101The disease: High triglyceridesThe developer: AmarinPeak projections: $3.2 billion (Leerink Swann) Amarin has driven up its share price with stellar data from a pair of Phase III Read more...
Latest Headlines
- December 13, 2011
- November 28, 2011
- October 25, 2011
- September 28, 2011
- August 26, 2011
- April 18, 2011
- January 12, 2011
- November 29, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
